CFTR Is a Negative Regulator of NFκB Mediated Innate Immune Response
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Dysfunctional CFTR in the airways is associated with elevated levels of NFkappaB mediated IL-8 signaling leading to neutrophil chemotaxis and chronic lung inflammation in cystic fibrosis. The mechanism(s) by which CFTR mediates inflammatory signaling is under debate. METHODOLOGY/PRINCIPAL FINDINGS: We tested the hypothesis that wt-CFTR down-regulates NFkappaB mediated IL-8 secretion. We transiently co-expressed wt-CFTR and IL-8 or NFkappaB promoters driving luciferase expression in HEK293 cells. Wt-CFTR expression in HEK293 cells suppresses both basal and IL1beta induced IL-8, and NFkappaB promoter activities as compared to the control cells transfected with empty vector (p<0.05). We also confirmed these results using CFBE41o- cells and observed that cells stably transduced with wt-CFTR secrete significantly lower amounts of IL-8 chemokine as compared to non-transfected control cells. To test the hypothesis that CFTR must be localized to cell surface lipid rafts in polarized airway epithelial cells in order to mediate the inflammatory response, we treated CFBE41o- cells that had been stably transduced with wt-CFTR with methyl-beta-cyclodextrin (CD). At baseline, CD significantly (p<0.05) induced IL-8 and NFkappaB reporter activities as compared to control cells suggesting a negative regulation of NFkappaB mediated IL-8 signaling by CFTR in cholesterol-rich lipid rafts. Untreated cells exposed to the CFTR channel blocker CFTR-172 inhibitor developed a similar increase in IL-8 and NFkappaB reporter activities suggesting that not only must CFTR be present on the cell surface but it must be functional. We verified these results in vivo by comparing survival, body weight and pro-inflammatory cytokine response to P. aeruginosa LPS in CFTR knock out (CFKO) mice as compared to wild type controls. There was a significant (p<0.05) decrease in survival and body weight, an elevation in IL-1beta in whole lung extract (p<0.01), as well as a significant increase in phosphorylated IkappaB, an inducer of NFkappaB mediated signaling in the CFKO mice. CONCLUSIONS/SIGNIFICANCE: Our data suggest that CFTR is a negative regulator of NFkappaB mediated innate immune response and its localization to lipid rafts is involved in control of inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Webb, A. K. (2006) · Cited by 4,369
Rowe, S. M., Miller, S., & Sorscher, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043184 · Cited by 1,398
Yoshimura, T., Matsushima, K., Tanaka, S., Robinson, E. A., Appella, E., Oppenheim, J. J., & Leonard, E. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9233 · Cited by 982 · cited 1×
“neutrophils [4] that has been implicated in a number of inflammatory diseases, such as cystic fibrosis (CF) [5], adult respiratory distress syndrome [6], chronic obstructive pulmonary disease (COPD), and asthma [7].”
BackgroundCFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells.
Cozens, A. L., Yezzi, M. J., Kunzelmann, K., Ohrui, T., Chin, L., Eng, K., Finkbeiner, W. E., Widdicombe, J. H., & Gruenert, D. C. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.10.1.7507342 · Cited by 929 · cited 2×
“Cell Culture and Reagents The HEK293, CFBE41o- (cystic fibrosis bronchial epithelial cell lines, originally immortalized and characterized by Dr. Dieter Gruenert[41,42]), CFBE41o-wtCFTR or CFBE41o-DF08-CFTR (stably transduced with wt-CFTR or DF08-CFTR by Dr. JP Clancy[43]) cell lines were maintained in DMEM/F12 and ME…”
BackgroundInfluentialStandiford, T. J., Kunkel, S. L., Basha, M. A., Chensue, S. W., Lynch, J. P., Toews, G. B., Westwick, J., & Strieter, R. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114928 · Cited by 687 · cited 1×
“The airway epithelium is one of the several sources of IL-8 in the airway [8].”
BackgroundInterleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups
Donnelly, S. C., Haslett, C., Strieter, R. M., Kunkel, S. L., Walz, A., Robertson, C. R., Carter, D. C., Pollok, A. J., & Grant, I. S. (1993) · The Lancet · doi:10.1016/0140-6736(93)90416-e · Cited by 676 · cited 1×
“neutrophils [4] that has been implicated in a number of inflammatory diseases, such as cystic fibrosis (CF) [5], adult respiratory distress syndrome [6], chronic obstructive pulmonary disease (COPD), and asthma [7].”
BackgroundKonstan, M. W., Hilliard, K. A., Norvell, T. M., & Berger, M. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.2.8049828 · Cited by 520 · cited 1×
“The exaggerated inflammatory responses in chronic diseases such as CF contribute to neutrophil-driven lung destruction [9–11].”
BackgroundGenetic Modifiers of Lung Disease in Cystic Fibrosis
Drumm, M. L., Konstan, M. W., Schluchter, M. D., Handler, A., Pace, R., Zou, F., Zariwala, M., Fargo, D., Xu, A., Dunn, J. M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051469 · Cited by 504 · cited 1×
“This may explain why mutations or single nucleotide polymorphisms (SNPs) of these receptors have the modifier function in CF or CF like diseases[37–39].”
BackgroundNakamura, H., Yoshimura, K., McElvaney, N. G., & Crystal, R. G. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115738 · Cited by 487 · cited 1×
“neutrophils [4] that has been implicated in a number of inflammatory diseases, such as cystic fibrosis (CF) [5], adult respiratory distress syndrome [6], chronic obstructive pulmonary disease (COPD), and asthma [7].”
BackgroundDiMango, E., Zar, H. J., Bryan, R., & Prince, A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118275 · Cited by 433 · cited 1×
“Several cytokines such as IL1-b, tumor necrosis factor (TNF)-a, interferon (IFN)-c and bacterial products, induce NFkB mediated IL-8 release from airway epithelial cells [12,13], thus exacerbating the baseline inflammatory milieu in CF.”
BackgroundMarini, M., Vittori, E., Hollemborg, J., & Mattoli, S. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90223-o · Cited by 409 · cited 1×
“, chronic obstructive pulmonary disease (COPD), and asthma”
BackgroundProtease-antiprotease imbalance in the lungs of children with cystic fibrosis.
Birrer, P., McElvaney, N. G., Rüdeberg, A., Sommer, C. W., Liechti-Gallati, S., Kraemer, R., Hubbard, R., & Crystal, R. G. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.1.7912987 · Cited by 382 · cited 1×
“The exaggerated inflammatory responses in chronic diseases such as CF contribute to neutrophil-driven lung destruction [9–11].”
BackgroundLower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis
Armstrong, D. S., Grimwood, K., Carzino, R., Carlin, J. B., Olinsky, A., & Phelan, P. D. (1995) · BMJ · doi:10.1136/bmj.310.6994.1571 · Cited by 357 · cited 1×
“The exaggerated inflammatory responses in chronic diseases such as CF contribute to neutrophil-driven lung destruction [9–11].”
BackgroundDiMango, E., Ratner, A. J., Bryan, R., Tabibi, S., & Prince, A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2865 · Cited by 323 · cited 1×
“. This hyper-inflammatory response was also observed in both human CF respiratory epithelial cell lines”
BackgroundHeeckeren, A., Walenga, R., Konstan, M. W., Bonfield, T., Davis, P. B., & Ferkol, T. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119828 · Cited by 262 · cited 1×
“This hyper-inflammatory response was also observed in both human CF respiratory epithelial cell lines[21] and in CF transmembrane conductance regulator deficient homozygous mice (CFTR2/2) compared to normal controls after Pseudomonas aeruginosa stimulation [22].”
BackgroundWeber, A. J., Soong, G., Bryan, R. A., Saba, S., & Prince, A. S. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l71 · Cited by 193
Innate immune response in CF airway epithelia: hyperinflammatory?
Machen, T. E. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00605.2005 · Cited by 184 · cited 1×
“Excessive inflammation in the CF airway may be largely responsible for the development of bronchiectasis, but it has not been clear if chronic infection is always a factor[16,17].”
BackgroundSide chain and backbone contributions of Phe508 to CFTR folding
Thibodeau, P. H., Brautigam, C. A., Machius, M., & Thomas, P. J. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb881 · Cited by 169 · cited 1×
“[2].”
Vij, N., Fang, S., & Zeitlin, P. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600509200 · Cited by 167
Self-citationIsolation of CF cell lines corrected at ΔF508-CFTR locus by SFHR-mediated targeting
Bruscia, E. M., Sangiuolo, F. C., Sinibaldi, P., Goncz, K. K., Novelli, G., & Gruenert, D. C. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301741 · Cited by 166 · cited 1×
“Dieter Gruenert[41,42]), CFBE41o-wtCFTR or CFBE41o-DF08-CFTR (stably transduced with wt-CFTR or DF08-CFTR by Dr.”
BackgroundKowalski, M. P., & Pier, G. B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.418 · Cited by 160 · cited 1×
“aeruginosa or proinflammatory stimulus[23,40], we anticipate that this may be a homeostatic mechanism to control inflammation.”
BackgroundUpdate on gene modifiers in cystic fibrosis
Collaco, J. M., & Cutting, G. R. (2008) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283121cdc · Cited by 143 · cited 1×
“This may explain why mutations or single nucleotide polymorphisms (SNPs) of these receptors have the modifier function in CF or CF like diseases[37–39].”
BackgroundProcessing and function of CFTR-ΔF508 are species-dependent
Ostedgaard, L. S., Rogers, C. S., Dong, Q., Randak, C. O., Vermeer, D. W., Rokhlina, T., Karp, P. H., & Welsh, M. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706974104 · Cited by 128 · cited 2×
“[24].”
BackgroundNovel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro.
Massion, P. P., Inoue, H., Richman–Eisenstat, J., Grünberger, D., Jorens, P. G., HOUSSET, B., Pittet, J., Wiener-Kronish, J. P., & Nadel, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116954 · Cited by 125 · cited 1×
“Several cytokines such as IL1-b, tumor necrosis factor (TNF)-a, interferon (IFN)-c and bacterial products, induce NFkB mediated IL-8 release from airway epithelial cells [12,13], thus exacerbating the baseline inflammatory milieu in CF.”
BackgroundSchroeder, T. H., Reiniger, N., Meluleni, G. J., Grout, M., Coleman, F. T., & Pier, G. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7410 · Cited by 113 · cited 1×
“aeruginosa LPS from outer membrane into epithelial cells and activates NFkB signaling [34,35].”
BackgroundActivation of the Unfolded Protein Response by ΔF508 CFTR
Bartoszewski, R., Rab, A., Jurkuvenaite, A., Mazur, M., Wakefield, J., Collawn, J. F., & Bebők, Z. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0065oc · Cited by 106 · cited 2×
“We and others have observed that transient or stable over expression of DF508-CFTR in HEK-293 or CFBE cells results in decreased NFkB transcriptional activity (Fig S4), but expression of another type of CFTR mutation does not[31–33].”
BackgroundJoseph, T. D., Look, D. C., & Ferkol, T. W. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00066.2004 · Cited by 103 · cited 2×
“Several recent reports have demonstrated that lung epithelial cells expressing mutant CFTR have increased production of proinflammatory cytokines and exaggerated NFkBactivation[25–29].”
BackgroundDysregulated Cytokine Production in Human Cystic Fibrosis Bronchial Epithelial Cells
Stecenko, A. A., King, G. A., Torii, K., BREYER, R. M., Dworski, R., Blackwell, T. S., Christman, J. W., & Brigham, K. L. (2001) · Inflammation · doi:10.1023/a:1011080229374 · Cited by 101 · cited 2×
“Several recent reports have demonstrated that lung epithelial cells expressing mutant CFTR have increased production of proinflammatory cytokines and exaggerated NFkBactivation[25–29].”
BackgroundSrivastava, M., Eidelman, O., Zhang, J., Paweletz, C. P., Caohuy, H., Yang, Q., Jacobson, K. A., Heldman, E., Huang, W., Jozwik, C., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402030101 · Cited by 93
Zaman, M. M., Gelrud, A., Junaidi, O., Regan, M. M., Warny, M., Shea, J. C., Kelly, C. P., O'Sullivan, B. P., & Freedman, S. D. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.5.819-824.2004 · Cited by 85 · cited 1×
“cells have increased basal levels of pro-inflammatory C-X-C chemokine, interleukin (IL)-8, attributed to activated NFkB [3].”
BackgroundRab, A., Bartoszewski, R., Jurkuvenaite, A., Wakefield, J., Collawn, J. F., & Bebők, Z. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00391.2006 · Cited by 81 · cited 2×
“We and others have observed that transient or stable over expression of DF508-CFTR in HEK-293 or CFBE cells results in decreased NFkB transcriptional activity (Fig S4), but expression of another type of CFTR mutation does not[31–33].”
BackgroundDudez, T. S., Borot, F., Huang, S. L., Kwak, B. R., Bacchetta, M., Ollero, M., Stanton, B. A., & Chanson, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.01.007 · Cited by 80 · cited 4×
“The absence of CFTR in DRMs was associated with abnormal TNFR1 signaling as verified by no recruitment of TNFR1 and c-Src to lipid rafts in CFTR-DTRL cells and loss of regulation of gap junctional communication (GJIC) and IL-8 secretion[23].”
BackgroundInfluentialBartoszewski, R., Rab, A., Twitty, G., Stevenson, L., Fortenberry, J., Piotrowski, A., Dumanski, J. P., & Bebök, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707610200 · Cited by 77 · cited 2×
“We and others have observed that transient or stable over expression of DF508-CFTR in HEK-293 or CFBE cells results in decreased NFkB transcriptional activity (Fig S4), but expression of another type of CFTR mutation does not[31–33].”
BackgroundCHOP Transcription Factor Mediates IL-8 Signaling in Cystic Fibrosis Bronchial Epithelial Cells
Vij, N., Amoako, M. O., Mazur, S., & Zeitlin, P. L. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0197oc · Cited by 65 · cited 1×
“The IL-8 chemokine secretion in media was similarly quantified using an EASIA system (Invitrogen) as described before[18].”
MethodSelf-citationTseng, J., Do, J., Widdicombe, J. H., & Machen, T. E. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00166.2005 · Cited by 55 · cited 1×
“Excessive inflammation in the CF airway may be largely responsible for the development of bronchiectasis, but it has not been clear if chronic infection is always a factor[16,17].”
BackgroundDysregulated NF-κB activation in cystic fibrosis: evidence for a primary inflammatory disorder
Blackwell, T. S., Stecenko, A. A., & Christman, J. W. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.281.1.l69 · Cited by 53 · cited 2×
“Several recent reports have demonstrated that lung epithelial cells expressing mutant CFTR have increased production of proinflammatory cytokines and exaggerated NFkBactivation[25–29].”
BackgroundGene modifiers of lung disease
Knowles, M. R. (2006) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000245707.59138.40 · Cited by 39 · cited 1×
“This may explain why mutations or single nucleotide polymorphisms (SNPs) of these receptors have the modifier function in CF or CF like diseases[37–39].”
Background
Cited by
Cystic fibrosis: a mucosal immunodeficiency syndrome
Cohen, T. S., & Prince, A. (2012) · Nature Medicine · doi:10.1038/nm.2715 · Cited by 484
Luciani, A., Villella, V. R., Esposito, S., Brunetti-Pierri, N., Medina, D., Settembre, C., Gavina, M., Pulze, L., Giardino, I., Pettoello-Mantovani, M., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2090 · Cited by 467
“and activation of NF-κB secondary to defective CFTR functio”
BackgroundVillella, V. R., Esposito, S., Bruscia, E. M., Maiuri, M. C., Raia, V., Kroemer, G., & Maiuri, L. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00001 · Cited by 389
The role of Nuclear Factor-kappa B signaling in human cervical cancer
Tilborghs, S., Corthouts, J., Verhoeven, Y., Arias, D., Rolfo, C., Trinh, X. B., & van Dam, P. A. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.11.001 · Cited by 269
Levitan, I., Fang, Y., Rosenhouse-Dantsker, A., & Romanenko, V. (2010) · Subcellular Biochemistry · doi:10.1007/978-90-481-8622-8_19 · Cited by 247
Metadata
- Authors
- Vij, N., Mazur, S., & Zeitlin, P. L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-02-27
- Volume
- 4
- Issue
- 2
- Pages
- e4664
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2063565576
- Cited by
- 166
- References
- 37
- FWCI
- 16.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.